Maternal stress and fetoplacental cortisol regulation in small-for-gestational-age newborns
Por:
Miranda, J, Benitez, L, Macías-Redondo, S, Paules, C, Gomez-Gomez, A, Basso, A, Crovetto, F, Youssef, L, Pozo, OJ, Schoorlemmer, J, Crispi, F and Gratacós, E
Publicada:
1 jun 2025
Ahead of Print:
1 may 2025
Resumen:
Objective Previous research has identified an association between maternal stress, fetal growth and the expression of glucocorticoid-related genes in the placenta, particularly 11-beta hydroxysteroid dehydrogenase-2 (HSD11 beta 2). However, to date, no studies have simultaneously explored the relationships between maternal stress, placental expression and methylation of HSD11 beta 2, and fetal cortisol metabolites according to fetal growth. The aim of the present study was to evaluate the association between perceived antenatal maternal stress, the expression and methylation of the placental HSD11 beta 2 gene, fetal cortisol metabolites in amniotic fluid and birth weight. Methods This nested case-control study, which was part of a large prospective cohort study, was conducted at two maternofetal medicine units in Barcelona, Spain (BCNatal: Hospitals Clinic and Sant Joan de D & eacute;u). We enrolled singleton pregnancies and classified neonates as small-for-gestational-age (SGA) if their birth weight was below the 10th percentile (n = 343) or as appropriate-for-gestational-age (AGA) controls (n = 399). The Perceived Stress Scale (PSS) and the State-Trait Anxiety Inventory (STAI) scores were obtained to assess maternal stress and anxiety levels. We analyzed placental HSD11 beta 2 RNA expression (n = 44 SGA and 28 AGA) and DNA methylation levels (n = 89 SGA and 34 AGA), and fetal cortisol metabolites and the activity of metabolizing enzymes in amniotic fluid (n = 135 SGA and 78 AGA) using liquid chromatography-tandem mass spectrometry. Results Median maternal perceived stress (PSS, 23 (interquartile range (IQR), 17-28) vs 20 (IQR, 15-26); P < 0.001) and median anxiety state (STAI-state, 19.0 (IQR, 14.0-29.0) vs 16.0 (IQR, 11.0-24.0); P < 0.001) scores were significantly higher in the SGA group compared with the control group. SGA cases showed lower median placental HSD11 beta 2 RNA expression (Delta Ct, 50.5 (IQR, 21.6-106.0) vs 92.7 (IQR, 62.3-118.0); P = 0.013) with similar DNA methylation levels (mean +/- SD, 10.7 +/- 3.0% vs 11.0 +/- 2.8%; P = 0.648) compared with AGA controls. Analysis of amniotic fluid revealed altered cortisol metabolism in SGA fetuses, with increased median 5 alpha-tetrahydrocortisol concentration (SGA, 0.09% (IQR, 0.06-0.15%) vs controls, 0.07% (IQR, 0.05-0.11%); P = 0.020) and activity of its related enzyme (5 alpha-reductase activity in SGA, 0.19% (IQR, 0.14-0.31%) vs controls, 0.17% (IQR, 0.12-0.22%); P = 0.007), together with a decrease in median 6-hydroxycortisol concentration (SGA, 0.09% (IQR, 0.06-0.11%) vs controls, 0.11% (IQR, 0.08-0.12%); P < 0.001) and activity of its related enzyme (CYP3A7 activity in SGA, 0.19% (IQR, 0.11-0.25%) vs controls, 0.24% (IQR, 0.17-0.33%); P < 0.001). Conclusions SGA pregnancy is associated with high perceived maternal stress and dysregulated fetoplacental cortisol metabolism. These results deepen our understanding of the pathophysiology of SGA and highlight the potential benefit of intervention to mitigate maternal stress. (c) 2025 International Society of Ultrasound in Obstetrics and Gynecology.
Filiaciones:
Miranda, J:
Univ Barcelona, Hosp Sant Joan Deu, BCNatal Barcelona Ctr Maternal Fetal & Neonatal Me, Barcelona, Spain
Univ Barcelona, Hosp Sant Joan Deu, Barcelona, Spain
Univ Cartagena, Fac Med, Dept Obstet & Gynecol, Cartagena, Colombia
Ctr Hosp Serena Mar, Dept Obstet & Gynecol, Cartagena, Colombia
Fdn Santa Fe Bogota, Bogota, Colombia
Benitez, L:
Univ Barcelona, Hosp Sant Joan Deu, BCNatal Barcelona Ctr Maternal Fetal & Neonatal Me, Barcelona, Spain
Univ Barcelona, Hosp Sant Joan Deu, Barcelona, Spain
Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain
Macías-Redondo, S:
Inst Aragones Ciencias Salud IACS, Zaragoza, Spain
Placental Pathophysiol & Fetal Programming Res Grp, Zaragoza, Spain
Paules, C:
Univ Barcelona, Hosp Sant Joan Deu, BCNatal Barcelona Ctr Maternal Fetal & Neonatal Me, Barcelona, Spain
Univ Barcelona, Hosp Sant Joan Deu, Barcelona, Spain
Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain
Inst Aragones Ciencias Salud IACS, Zaragoza, Spain
Placental Pathophysiol & Fetal Programming Res Grp, Zaragoza, Spain
Gomez-Gomez, A:
Hosp Mar Med Res Inst IMIM, Appl Metabol Res Grp, Barcelona, Spain
Basso, A:
Univ Barcelona, Hosp Sant Joan Deu, BCNatal Barcelona Ctr Maternal Fetal & Neonatal Me, Barcelona, Spain
Univ Barcelona, Hosp Sant Joan Deu, Barcelona, Spain
A Manzoni Hosp, Dept Obstet & Gynecol, ASST Lecco, Lecce, Italy
Crovetto, F:
Univ Barcelona, Hosp Sant Joan Deu, BCNatal Barcelona Ctr Maternal Fetal & Neonatal Me, Barcelona, Spain
Univ Barcelona, Hosp Sant Joan Deu, Barcelona, Spain
Inst Recerca Sant Joan Deu, Esplugues De Llobregatsp, Spain
Inst Salud Carlos III, Primary Care Intervent Prevent Maternal & Child Ch, Barcelona, Spain
:
Univ Barcelona, Hosp Sant Joan Deu, BCNatal Barcelona Ctr Maternal Fetal & Neonatal Me, Barcelona, Spain
Univ Barcelona, Hosp Sant Joan Deu, Barcelona, Spain
Hosp Clin Barcelona, Josep Carreras Leukaemia Res Inst, Univ Barcelona Campus, Barcelona, Spain
Pozo, OJ:
Hosp Mar Med Res Inst IMIM, Appl Metabol Res Grp, Barcelona, Spain
Schoorlemmer, J:
Inst Aragones Ciencias Salud IACS, Zaragoza, Spain
Placental Pathophysiol & Fetal Programming Res Grp, Zaragoza, Spain
ARAID Fdn, Zaragoza, Spain
Crispi, F:
Univ Barcelona, Hosp Sant Joan Deu, BCNatal Barcelona Ctr Maternal Fetal & Neonatal Me, Barcelona, Spain
Univ Barcelona, Hosp Sant Joan Deu, Barcelona, Spain
Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain
Ctr Biomed Res Rare Dis CIBER ER, Barcelona, Spain
Gratacós, E:
Univ Barcelona, Hosp Sant Joan Deu, BCNatal Barcelona Ctr Maternal Fetal & Neonatal Me, Barcelona, Spain
Univ Barcelona, Hosp Sant Joan Deu, Barcelona, Spain
Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain
Inst Recerca Sant Joan Deu, Esplugues De Llobregatsp, Spain
Ctr Biomed Res Rare Dis CIBER ER, Barcelona, Spain
Green Submitted, hybrid
|